Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results

Go back to Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
(NASDAQ: AMLX) Delayed: 38.66 -1 (2.52%)
Previous Close $39.66    52 Week High
Open $39.79    52 Week Low
Day High $41.14    P/E N/A 
Day Low $38.35    EPS
Volume 4,642,720